Aktis Oncology Raises $72 Million From Bristol-Myers Squibb Co (NYSE:BMY) And Novartis AG (NYSE:NVS) In Series A Round For The Development Of Radiopharmaceutical Treatments
Aktis Oncology raised $72 million in Series A round from investors like Bristol-Myers Squibb Co (NYSE:BMY) and Novartis AG (NYSE:
Read more